Clinical Trial Update: Co-Administration Of Methotrexate And CP-690,550 [Phase 1]

View source ↗

Summary

Phase 1 results report on co-administering methotrexate with CP-690,550 (tofacitinib) in rheumatoid arthritis; results were posted in December 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CP-690,550 (tofacitinib)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2012-12-07